1.0Quantix Italiahttps://quantixitalia.com/en/Paolo Sandrinihttps://quantixitalia.com/en/author/bd1c15e9accb7876/Drugs - Quantix Italiarich600338<blockquote class="wp-embedded-content" data-secret="tJiDfbtZh9"><a href="https://quantixitalia.com/en/drugs/">Drugs</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://quantixitalia.com/en/drugs/embed/#?secret=tJiDfbtZh9" width="600" height="338" title="“Drugs” — Quantix Italia" data-secret="tJiDfbtZh9" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://quantixitalia.com/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
https://quantixitalia.com/wp-content/uploads/2024/10/farmaci2.jpg17921024MONOBEST drug Our research and development activities, carried out in collaboration with the University of Insubria, enabled us to obtain the European patent "Peripheral blood mononucleate cells formulations subjected to hypoxia."